Contact for more Information
Technology Alerts minus

Sign up to receive TIDO’s monthly newsletter highlighting new Children’s Hospital technologies and research and development partnership opportunities.

sign me up
send to a friend

CMCC 1595

A small molecule drug as a topical treatment for small fiber peripheral neuropathy

Inventors: Gabriel Corfas, Joshua Murtie

Categories: Therapeutics

SubCategories: Endocrinology, Neurology/Neuroscience

Keywords: Drug Discovery

Invention Description:

A small molecule that enhances ligand-induced signaling by the Glial Derived Neurotrophic Factor receptor (GFR-alpha/RET) family, which when applied topically in mouse models of small fiber peripheral neuropathy prevents nerve degeneration and preserves sensory function.


Peripheral neuropathy is very prevalent and can be caused by many diseases and disorders. Applications include neuropathies caused by:

• Chemotherapy
• Cancer
• Lupus
• Diabetes
• Shingles
• Alcoholism

Competitive Advantages:

There are no products currently available to directly treat the underlying causes of nerve damage; the current treatments (antidepressants, anticonvulsants, lidocaine patches) only alleviate the symptoms but do not treat the associated nerve damage or address the disease that has neuropathy as a side effect. The topical use is expected to be safer and have fewer side effects than the oral administration.

Business Opportunity:

• Exclusive License
• Partnerships for Development

Key Publications: Manuscript in press (PNAS)

IPStatus: Patented

Terms and Conditions children's hospital
Site Designed and Developed by Genuine